Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Marram Investment Management. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+2.7%
YTD+3.2%
Annualized+13.5%
Positioning StanceNEUTRAL
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Marram holds 47% cash amid elevated valuations and macro uncertainty, maintaining core positions in energy infrastructure MLPs, regional banks, payment technology, and biopharma."
Executive Summary
Marram returned +2.7% net in Q2 2026 and +3.2% YTD, bringing since-inception annualized returns to +13.7%. The portfolio remains conservatively positioned with 47% cash amid high valuations and multiple macroeconomic risks including reversing profitability tailwinds, AI-driven business uncertainty, and speculative assumptions embedded in current prices. Energy infrastructure MLPs at 29% NAV remain a cornerstone holding given stable cash flows, reasonable valuations at ~10x cash flow, and inflation protection. Regional banks at 9% NAV have delivered 30%+ IRR since the March 2023 crisis purchases, though exposure has been prudently reduced due to expanded valuations and easing credit standards. Payment technology holdings at 8% NAV are down 23% YTD as capital rotates into AI and semiconductors, but the manager plans to add if prices decline further. Biopharma at 7% NAV positions for recovery in industry R&D spend from cyclical lows. The manager exited PayPal after CEO change broke the thesis and ICON plc after moat deterioration, while adding to Berkshire Hathaway. The strategy remains patient opportunism, with ample dry powder awaiting deployment at target Wishlist prices.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
62%
CautiousHigh
Moderate (62%)
Manager demonstrates moderate-high conviction through concentrated portfolio of 4-5 main allocations with specific sizing disclosed (29% MLPs, 9% financials, 8% payments, 7% biopharma, 5.5% Berkshire). Provides clear thesis for each holding with specific valuation metrics (10x cash flow for MLPs, 3X return in 5 years for payments, 30%+ IRR achieved on banks). Willing to exit positions when thesis breaks (PayPal, ICON plc) and add to positions when management signals value (Berkshire buybacks). However, the 47% cash position and diversified basket approach to biopharma moderates conviction. Manager is decisive about holdings but also highly selective, which caps the score below high-conviction concentrated funds.
Growth Outlook
33%
BearishBullish
Bearish (33%)
Manager expresses caution about the market environment, noting that valuations across many sectors reflect optimistic, near speculative assumptions. Highlights that decades-long tailwinds supporting corporate profitability are reversing or becoming less reliable. States that elevated expectations applied to potentially less profitable outcomes create a recipe for future volatility. However, not fully bearish as manager continues to hold equity positions and sees selective opportunities, just at lower prices than currently available.
Risk Appetite
26%
DefensiveAggressive
Defensive (26%)
Portfolio is defensively positioned with 47% cash, the highest allocation in the portfolio. Manager has been reducing exposure across multiple positions over the past 2 years including MLPs (from 42% to 29%) and regional banks. Exited two positions entirely (PayPal and ICON plc). Favors a bird-in-hand approach preferring current cash flow generation. This is clearly a risk-off, defensive tilt with substantial cash raised and held intentionally.
Capital Deployment
33%
De-riskingDeploying
De-risking (33%)
Net capital has been pulled back over the past 2 years. MLP allocation reduced from 42% peak to 29% through harvested gains and trimming. Regional bank exposure prudently reduced over 2 years. Two positions exited entirely (PayPal, ICON plc). Cash position stands at 47% of NAV, the largest allocation in the portfolio. While manager added to Berkshire Hathaway, this appears to be rotation rather than net new deployment. Overall trajectory is clearly de-risking with cash raised and held intentionally as dry powder, scoring in the moderate de-risking range.
Forward Guidance
29%
CautiousExpansionary
Cautious (29%)
Manager is explicitly waiting for better prices before deploying the 47% cash position. States will act when Wishlist prices are reached, and if not, will wait. This is not residual cash but intentional dry powder. Manager does indicate willingness to add to payment technology if prices move lower, but overall stance is one of patience and waiting rather than active deployment. The 4% interest collection on cash while waiting reinforces this is a deliberate holding pattern, not preparation for imminent deployment.
Language Signal
36%
BearishBullish
Balanced (36%)
Language is balanced but leans cautious. Risk-oriented language includes: speculative assumptions, potent recipe for volatility, uncertainty, risks avoided, deteriorating moat, unhealthy competitive dynamics, lack of pricing power. Opportunity language includes: favorable dynamics, attractive prices, satisfactory outcome, long-term view, capital will return. The letter discusses both risks and opportunities but devotes more space to explaining caution and defensive positioning. Net balance tilts modestly bearish in directional language.
Perceived Risk
68%
Low RiskElevated
Elevated Risk (68%)
Manager identifies multiple specific, named macro risks with meaningful discussion. Explicitly lists reversing profitability tailwinds (geopolitics, free trade, supply chains, demographics, interest rates). Flags AI introducing broad, complex, fast-moving uncertainty into business profit pools. Notes valuations reflect optimistic, near speculative assumptions. States elevated expectations plus less predictable outcomes equal potent recipe for future volatility. Also identifies sector-specific risk of easing credit underwriting standards in banking. These are not passing mentions but central to the letter's positioning rationale, with detailed explanation of each risk factor.
Opportunity Density
38%
ScarceAbundant
Selective (38%)
Manager characterizes the current environment as requiring patience and selectivity. Holds 47% cash because opportunities at acceptable prices are scarce. States will wait for Wishlist prices to be reached, and if not reached, will continue waiting. This language indicates a sparse opportunity set at current market levels. Manager does see selective opportunities in existing holdings if prices decline (payment technology) and maintains positions in MLPs and other sectors, but overall tone emphasizes the difficulty of finding compelling ideas at current valuations. The need to hold nearly half the portfolio in cash signals limited opportunity density.
Time Horizon
78%
Short-TermLong-Term
Decade+ (78%)
Manager demonstrates a multi-year investment horizon with explicit long-term framing. States the fund is focused on growing wealth for retirement or legacy purposes. Describes MLPs as a cornerstone holding with reference to 2019 and 2021 letters for the original thesis. Payment technology investments expected to generate 3X return in 5 years. Biopharma positioned for long-term recovery with the view that society will continue to need health innovations over time. Strategy described as patient opportunism with willingness to wait indefinitely for Wishlist prices. Portfolio manager has majority of family liquid net worth invested in the same strategy, reinforcing long-term commitment. No near-term catalyst dependency evident. Time horizon is clearly multi-year with patience explicitly emphasized.